Abbott Laboratories (ABT) Current Assets (2009 - 2026)

Abbott Laboratories has disclosed Current Assets across 18 years of filings, most recently posting $25.5 billion for Q1 2026.

• Current Assets for Q1 2026 came in at $25.5 billion, up 10.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.5 billion (up 10.17% YoY), and the FY2025 annual result was $26.0 billion, up 9.89% from the prior year.
• Current Assets came in at $25.5 billion for Q1 2026 at Abbott Laboratories, down from $26.0 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $26.0 billion in Q4 2025 to a low of $22.4 billion in Q1 2024.
• The 5-year median for Current Assets is $23.8 billion (2024), against an average of $24.0 billion.
• Across the five-year window, Current Assets climbed 10.29% in 2022 and fell 10.13% in 2023, its largest moves.
• Abbott Laboratories' Current Assets stood at $25.2 billion in 2022, then dropped by 10.13% to $22.7 billion in 2023, then climbed by 4.35% to $23.7 billion in 2024, then increased by 9.89% to $26.0 billion in 2025, then fell by 1.88% to $25.5 billion in 2026.
• The last three Current Assets figures came in at $25.5 billion (Q1 2026), $26.0 billion (Q4 2025), and $24.8 billion (Q3 2025), per Business Quant data.